Jazz Pharmaceuticals, Inc. v. Ranbaxy Laboratories Limited et al.
consolidated/terminated- Docket:
- 2:14-cv-04467-ES-JAD
- Filed:
- 2014-07-15
- Terminated:
- 2015-04-22
Patents:84612036472431678088972622197851506826365083242757668730776510677651077895059845798885891828731963
Jazz Pharmaceuticals sued Ranbaxy Laboratories and Ranbaxy Inc. in a Hatch-Waxman ANDA patent infringement action over generic sodium oxybate referencing Xyrem. The complaint asserted multiple patents including U.S. Patent No. 8,461,203. The case was consolidated for all purposes into Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC, No. 13-391-ES-JAD, and administratively terminated.